These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27021467)

  • 1. PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles.
    Ahmed IS; El-Hosary R; Shalaby S; Abd-Rabo MM; Elkhateeb DG; Nour S
    Int J Pharm; 2016 May; 504(1-2):70-9. PubMed ID: 27021467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety Profiles of Oral Atorvastatin-Loaded Nanoparticles: Effect of Size Modulation on Biodistribution.
    Ahmed IS; El Hosary R; Hassan MA; Haider M; Abd-Rabo MM
    Mol Pharm; 2018 Jan; 15(1):247-255. PubMed ID: 29232954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissolution enhancement of atorvastatin calcium by co-grinding technique.
    Prabhu P; Patravale V
    Drug Deliv Transl Res; 2016 Aug; 6(4):380-91. PubMed ID: 26712124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin calcium encapsulated eudragit nanoparticles with enhanced oral bioavailability, safety and efficacy profile.
    Kumar N; Chaurasia S; Patel RR; Khan G; Kumar V; Mishra B
    Pharm Dev Technol; 2017 Mar; 22(2):156-167. PubMed ID: 26555483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia.
    Meena AK; Ratnam DV; Chandraiah G; Ankola DD; Rao PR; Kumar MN
    Lipids; 2008 Mar; 43(3):231-41. PubMed ID: 18196308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
    Girgis GNS
    Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles.
    Shilpi D; Kushwah V; Agrawal AK; Jain S
    Pharm Res; 2017 Jul; 34(7):1505-1516. PubMed ID: 28466393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
    Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of different types of nano drug delivery systems of atorvastatin for the treatment of hyperlipidemia.
    Mathur M; Devi Vemula K
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2048-2060. PubMed ID: 30073852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
    Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
    Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin in nano-particulate formulation abates muscle and liver affliction when coalesced with coenzyme Q10 and/or vitamin E in hyperlipidemic rats.
    Farrag SM; Hamzawy MA; El-Yamany MF; Saad MA; Nassar NN
    Life Sci; 2018 Jun; 203():129-140. PubMed ID: 29694831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of finasteride capsules-loaded drug nanoparticles: formulation, optimization, in vitro, and pharmacokinetic evaluation.
    Ahmed TA
    Int J Nanomedicine; 2016; 11():515-27. PubMed ID: 26893559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and investigation of high solid content PTX-loaded nanoparticles dispersion via nanoprecipitation method.
    Xiang Y; Xiao M; Han S; Xu S; Cao Y; Lv Z; Liu J; Liu J; Deng L; Dong A
    J Biomater Sci Polym Ed; 2014; 25(11):1144-58. PubMed ID: 24894948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimentally designed lyophilized dry emulsion tablets for enhancing the antihyperlipidemic activity of atorvastatin calcium: Preparation, in-vitro evaluation and in-vivo assessment.
    Salama AH; Basha M; El Awdan S
    Eur J Pharm Sci; 2018 Jan; 112():52-62. PubMed ID: 29117504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of capsaicin using MPEG-PCL nanoparticles.
    Peng W; Jiang XY; Zhu Y; Omari-Siaw E; Deng WW; Yu JN; Xu XM; Zhang WM
    Acta Pharmacol Sin; 2015 Jan; 36(1):139-48. PubMed ID: 25434988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjustable degradation and drug release of a thermosensitive hydrogel based on a pendant cyclic ether modified poly(ε-caprolactone) and poly(ethylene glycol)co-polymer.
    Wang W; Deng L; Liu S; Li X; Zhao X; Hu R; Zhang J; Han H; Dong A
    Acta Biomater; 2012 Nov; 8(11):3963-73. PubMed ID: 22835677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DoE based Olanzapine loaded poly-caprolactone nanoparticles decreases extrapyramidal effects in rodent model.
    Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
    Int J Pharm; 2018 Apr; 541(1-2):198-205. PubMed ID: 29474898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Readily restoring freeze-dried probilosomes as potential nanocarriers for enhancing oral delivery of cyclosporine A.
    Guan P; Lu Y; Qi J; Wu W
    Colloids Surf B Biointerfaces; 2016 Aug; 144():143-151. PubMed ID: 27085046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
    Ravi PR; Vats R; Dalal V; Gadekar N; N A
    Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.